Pseudomonas aeruginosa Evolutionary Adaptation and Diversification in Cystic Fibrosis Chronic Lung Infections  Craig Winstanley, Siobhan O’Brien, Michael.

Slides:



Advertisements
Similar presentations
Intrapopulation variability in mutator prevalence among urinary tract infection isolates of Escherichia coli  A. Couce, N. Alonso-Rodriguez, C. Costas,
Advertisements

Figure 1. Exploring and comparing context-dependent mutational profiles in various cancer types. (A) Mutational profiles of pan-cancer somatic mutations,
Development of resistance in Pseudomonas aeruginosa obtained from patients with cystic fibrosis at different times  F.B. Spencker, L. Staber, T. Lietz,
Intravenous antibiotics given for 2 weeks do not eradicate persistent Staphylococcus aureus clones in cystic fibrosis patients  C. Andersen, B.C. Kahl,
Rapid single-nucleotide polymorphism-based identification of clonal Pseudomonas aeruginosa isolates from patients with cystic fibrosis by the use of real-time.
Achromobacter species in cystic fibrosis: Cross-infection caused by indirect patient-to- patient contact  C.R. Hansen, T. Pressler, W. Ridderberg, H.K.
Frequency and molecular diversity of Pseudomonas aeruginosa upon admission and during hospitalization: a prospective epidemiologic study  Dominique S.
Typing of Pseudomonas aeruginosa strains from patients with cystic fibrosis: phenotyping versus genotyping  Nicole Renders, Alex van Belkum, Alfonso Barth,
Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients  R. Cantón, N. Cobos,
Pseudomonas aeruginosa infection in cystic fibrosis caused by an epidemic metallo-β- lactamase-producing clone with a heterogeneous carbapenem resistance.
Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients  Helle Krogh Johansen, Samuel.
Laboratory Diagnosis of Clostridium difficile Infection
Jodi E. Gustave, Joseph A. Jurcisek, Karen S. McCoy, Steven D
M. Staples, R. M. A. Graham, V. Hicks, J. Strachan, A
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Meropenem in cystic fibrosis patients infected with resistant Pseudomonas aeruginosa or Burkholderia cepacia and with hypersensitivity to β-lactam antibiotics 
F. Grosso, S. Quinteira, L. Peixe  Clinical Microbiology and Infection 
Rapid single-nucleotide polymorphism-based identification of clonal Pseudomonas aeruginosa isolates from patients with cystic fibrosis by the use of real-time.
A. Rougeron, S. Giraud, B. Razafimandimby, J. F. Meis, J. -P
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
Pseudomonas aeruginosa Evolutionary Adaptation and Diversification in Cystic Fibrosis Chronic Lung Infections  Craig Winstanley, Siobhan O’Brien, Michael.
West Nile virus outbreak in Israel in 2015: phylogenetic and geographic characterization in humans and mosquitoes  Y. Lustig, Z. Kaufman, B. Mannasse,
Genome sequencing and characterization of an extensively drug-resistant sequence type 111 serotype O12 hospital outbreak strain of Pseudomonas aeruginosa 
D. Worlitzsch, C. Rintelen, K. Böhm, B. Wollschläger, N. Merkel, M
A longitudinal analysis of chronic MRSA and Pseudomonas aeruginosa co-infection in cystic fibrosis: A single-center study  Maret L. Maliniak, Arlene A.
Luisa De Sordi, Varun Khanna, Laurent Debarbieux  Cell Host & Microbe 
A. Papa, K. Dumaidi, F. Franzidou, A. Antoniadis 
Molecular epidemiology of Staphylococcus aureus strains colonizing the lungs of related and unrelated cystic fibrosis patients  Nicole H.M. Renders, Alex.
Increased serum concentration of G-CSF in cystic fibrosis patients with chronic Pseudomonas aeruginosa pneumonia  P.Ø. Jensen, C. Moser, A. Kharazmi,
A. Oliver, A. Mena  Clinical Microbiology and Infection 
Multicenter study of the in vitro activity of cefepime in comparison with five other broad- spectrum antibiotics against clinical isolates of Gram-positive.
E.C. Böttger  Clinical Microbiology and Infection 
Evaluation of a nine-locus variable-number tandem-repeat scheme for typing of Pseudomonas aeruginosa  J.F. Turton, S.E. Turton, L. Yearwood, S. Yarde,
Lucas R. Hoffman, Hemantha D. Kulasekara, Julia Emerson, Laura S
Whole genome characterization of hepatitis B virus quasispecies with massively parallel pyrosequencing  F. Li, D. Zhang, Y. Li, D. Jiang, S. Luo, N. Du,
Significance of human β-defensins in the epithelial lining fluid of patients with chronic lower respiratory tract infections  S. Yanagi, J. Ashitani,
M. Unemo, V. Vorobieva, N. Firsova, T. Ababkova, I. Leniv, B. C
Implementation of European standards of care for cystic fibrosis ��� Control and treatment of infection  J.S. Elborn, M. Hodson, C. Bertram  Journal of.
P. aeruginosa in the paranasal sinuses and transplanted lungs have similar adaptive mutations as isolates from chronically infected CF lungs  Oana Ciofu,
Volume 16, Issue 9, Pages (May 2006)
In vitro selection of antibiotic resistance in Pseudomonas aeruginosa
Antimicrobial susceptibility in Escherichia coli of human and avian origin—a comparison of wild-type distributions  M. Sjölund, S. Bengtsson, J. Bonnedahl,
Pseudomonas aeruginosa infection in cystic fibrosis caused by an epidemic metallo-β- lactamase-producing clone with a heterogeneous carbapenem resistance.
S. David, M. Mentasti, J. Parkhill, V.J. Chalker 
Figure 1. Structure of resistance islands containing dfrA35 in IncC plasmids. (a) pEc158 resistance island and (b) ... Figure 1. Structure of resistance.
E. Saussereau, I. Vachier, R. Chiron, B. Godbert, I. Sermet, N
Comparison of type III secretion system virulence among fluoroquinolone-susceptible and -resistant clinical isolates of Pseudomonas aeruginosa  A. Wong-Beringer,
The mosaic genome structure and phylogeny of Shiga toxin-producing Escherichia coli O104:H4 is driven by short-term adaptation  K. Zhou, M. Ferdous, R.F.
Extensive diversification is a common feature of Pseudomonas aeruginosa populations during respiratory infections in cystic fibrosis  Abdul Ashish, Steve.
Volume 114, Issue 5, Pages (March 2018)
Diagnostic multiplex PCR assay for the identification of the Liverpool, Midlands 1 and Manchester CF epidemic strains of Pseudomonas aeruginosa  Joanne.
Comparative antimicrobial spectrum and activity of the desfluoroquinolone BMS (T-3811) tested against non-fermentative Gram-negative bacilli  W.
Evolution of Salmonella within Hosts
Evolution of Pseudomonas aeruginosa virulence in infected patients revealed in a Dictyostelium discoideum host model  E. Lelong, A. Marchetti, M. Simon,
Stenotrophomonas maltophilia in cystic fibrosis: Improved detection by the use of selective agar and evaluation of antimicrobial resistance  P. Goncalves-Vidigal,
A. McNally, F. Alhashash, M. Collins, A. Alqasim, K. Paszckiewicz, V
Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis  Geraint B. Rogers, Lucas R. Hoffman,
Evidence for Variable Selective Pressures at MC1R
Association between the introduction of a new cystic fibrosis inhaled antibiotic class and change in prevalence of patients receiving multiple inhaled.
Australian epidemic strain pseudomonas (AES-1) declines further in a cohort segregated cystic fibrosis clinic  Amanda L. Griffiths, Danielle F. Wurzel,
Michael D. Parkins, R. Andres Floto  Journal of Cystic Fibrosis 
Intrapopulation variability in mutator prevalence among urinary tract infection isolates of Escherichia coli  A. Couce, N. Alonso-Rodriguez, C. Costas,
Katrina A. Lythgoe, Andy Gardner, Oliver G. Pybus, Joe Grove 
High-resolution melting analysis for the detection of two erythromycin-resistant Bordetella pertussis strains carried by healthy schoolchildren in China 
Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents    Clinical Microbiology and Infection  Volume.
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
Joshua P. Metlay, Daniel E. Singer  Clinical Microbiology and Infection 
Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)—A cause for concern? 
Improved early diagnosis of Pseudomonas aeruginosa by real-time PCR to prevent chronic colonisation in a paediatric cystic fibrosis population  Elaine.
Clinical Microbiology and Infection
Presentation transcript:

Pseudomonas aeruginosa Evolutionary Adaptation and Diversification in Cystic Fibrosis Chronic Lung Infections  Craig Winstanley, Siobhan O’Brien, Michael A. Brockhurst  Trends in Microbiology  Volume 24, Issue 5, Pages 327-337 (May 2016) DOI: 10.1016/j.tim.2016.01.008 Copyright © 2016 The Authors Terms and Conditions

Figure 1 Pathoadaptive Mutations in Pseudomonas aeruginosa. Genes encoding regulatory proteins are highlighted in red. Genes encoding sigma factors are highlighted in blue. Trends in Microbiology 2016 24, 327-337DOI: (10.1016/j.tim.2016.01.008) Copyright © 2016 The Authors Terms and Conditions

Figure 2 Key Figure: Phenotypic Heterogeneity within Pseudomonas aeruginosa Populations in Cystic Fibrosis (CF) The figure shows a population structure based on 15 variable traits using the eBURST algorithm [83]. From ten patients infected with the Liverpool epidemic strain (LES) of P. aeruginosa, 1720 isolates from 43 different sputum samples were analysed, giving rise to 398 unique ‘subtypes’ of the LES. Each sphere represents a different subtype. The size reflects the relative abundance of each subtype. Two subtypes connected by a single line differ in only one characteristic. The pie chart inset indicates the percentage contribution to diversity of variation between patients, between samples or within samples, demonstrating the major contribution of the latter. Adapted from [43]. Trends in Microbiology 2016 24, 327-337DOI: (10.1016/j.tim.2016.01.008) Copyright © 2016 The Authors Terms and Conditions

Figure 3 Variations in the Antimicrobial Susceptibilities of Pseudomonas aeruginosa within Individual Patients. The figure summarises, for four antibiotics, the spread of zone of inhibition data (ZOI) in mm for multiple isolates taken from 13 patients infected with the Liverpool epidemic strain (LES). For each patient, a minimum of 80 isolates was analysed, taken at multiple sampling points (40 isolates per sample point). The red line indicates the recognised cut-off points as defined by the British Society for Antimicrobial Susceptibility [84]. Note the tendency for isolates from the same patient to occur both above (susceptible) and below (resistant) the red line. Data adapted from two studies [43,46]. Trends in Microbiology 2016 24, 327-337DOI: (10.1016/j.tim.2016.01.008) Copyright © 2016 The Authors Terms and Conditions

Figure 4 Within-patient Variations in the Prevalence and Location within a Gene of Common Pathoadaptive Mutations. Based on sets of 40 isolates from a single sputum sample, for each of nine patients infected with the Liverpool epidemic strain, the prevalence and location of mutations is indicated for the lasR and mucA genes (with location relative to amino acid position on the predicted protein sequence indicated on the scale). Each patient is represented by the space between lines. Each circle represents the location of a mutation that is either severe (red; e.g., a frame-shift), a nonsynonymous single nucleotide polymorphism (orange; e.g., a single amino acid change), or a change that would not impact on the protein sequence (green). The size of the circle reflects the relative abundance in each set of 40 isolates (e.g., the severe lasR mutation in patient 9 was present in all 40 isolates tested). Analysis of data from a published study [53]. Trends in Microbiology 2016 24, 327-337DOI: (10.1016/j.tim.2016.01.008) Copyright © 2016 The Authors Terms and Conditions